Product Information
ACAMPROSATE CALC DR 333 MG TAB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.6103 per EA under NDC 68462043518. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jul 16, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
333 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462043518
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACAMPROSATE CALCIUMApproval Type
Generic (ANDA)
FDA Application
ANDA202229FDA Approved
7/16/2013
TE Code
AB
On Market Since
7/16/2013
Price Statistics
The NADAC for ACAMPROSATE CALC DR 333 MG TAB has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 14.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6103 per EA |
|---|---|
| All-time high | $1.1432 (Aug 10, 2016) |
| All-time low | $0.2971 (Nov 20, 2024) |
| 52-week high | $0.6218 |
| 52-week low | $0.5867 |
| Median price | $0.6946 |
| Average price | $0.6840 |
| Largest weekly change | +76.4% (Feb 12, 2025) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ACAMPROSATE CALC DR 333 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ACAMPROSATE CALC DR 333 MG TAB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.6103 per EA (NDC 68462043518), effective Aug 19, 2026.
How has the price of ACAMPROSATE CALC DR 333 MG TAB changed over time?
Over the history we have for it, the NADAC for ACAMPROSATE CALC DR 333 MG TAB has declined 14.6%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ACAMPROSATE CALC DR 333 MG TAB?
Since Nov 28, 2013, the NADAC for ACAMPROSATE CALC DR 333 MG TAB has ranged from a low of $0.2971 (Nov 20, 2024) to a high of $1.1432 (Aug 10, 2016), with a median of $0.6946 per EA.
Are there cheaper alternatives to ACAMPROSATE CALC DR 333 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ACAMPROSATE CALC DR 333 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures ACAMPROSATE CALC DR 333 MG TAB?
ACAMPROSATE CALC DR 333 MG TAB (NDC 68462043518) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.